Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on CogState.
RELATED STOCKHEAD STORIES
Experts
CRITERION: Do these ASX plays of the day deserve a sporting chance?
Experts
MoneyTalks: Why Aeris Resources and Cogstate are firmly on brokers’ Buy list
Health & Biotech
Check Up Budget Edition: Which ASX healthcare stocks will reap benefits from the Budget?
News
Market Highlights: Wall Street sweat on debt ceiling, CPI; and 5 ASX small caps to watch today
News
ASX Large Caps: Energy, Mining lead broad rally, Harvey Norman slumps 8pc on profit miss
News
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
News
Rise and Shine: Everything you need to know before the ASX opens
Health & Biotech
ASX Health Stocks: Most biotechs are still chasing maiden revenue, but here’s a few healthcare stocks with strong earnings
News
Top 10 at 10: Which ASX stocks are flying and floundering on Friday?
News
CLOSING BELL: Like glands through the shower glass, this was a day of our lives
Health & Biotech
Alzheimer’s drug no longer a moonshot as race heats up, ASX-listed Actinogen in the running
News
Rise and Shine: Everything you need to know before the ASX opens
Experts
CRITERION: Gains without pains? Maybe tackle these sporting injury stocks instead
Health & Biotech
ASX Health Stocks: New dawn for Alzheimer’s after Biogen’s landmark results; Cogstate soars by proxy
News
Rise and Shine: What you need to know before the ASX opens
News
Closing Bell: It’s not all bad news despite local, regional and small cap markets making an utter meal of Mercredi
Stockhead TV
